GU Cancers 2023 | The potential for the use of liquid biopsy for bladder cancer in clinical practice

Kyle M. Rose, MD, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, talks on the potential use of liquid biopsy for non-muscle invasive bladder cancer (NIMBC), including for the detection on minimal residue disease (MRD). This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.